11 – 20 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2016
-
Mark
Wound-healing factors can prime head and neck cancer cells to increase their tumor-forming capacity.
2016) In Laryngoscope(
- Contribution to journal › Article
- 2015
-
Mark
Anti- or pro-proliferation - Conditional options for TGF-α and cetuximab in head and neck squamous cell carcinoma.
(
- Contribution to journal › Article
-
Mark
An anesthetic method compatible with (18)F-FDG-PET studies in mice.
(
- Contribution to journal › Article
- 2014
-
Mark
Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma.
(
- Contribution to journal › Article
-
Mark
Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells
(
- Contribution to journal › Article
- 2013
-
Mark
Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3
(
- Contribution to journal › Article
- 2012
-
Mark
Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.
(
- Contribution to journal › Article
-
Mark
The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.
(
- Contribution to journal › Article
- 2009
-
Mark
Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.
(
- Contribution to journal › Article
-
Mark
No direct effects of erythropoietin beta on a head and neck squamous cell carcinoma cell line which is growth stimulated in vivo.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »